CBPO [China Biologic Products] 8-K: FOR RELEASE May 4, 2016 China Biologic Reports

[FOR RELEASE May 4, 2016 China Biologic Reports Financial Results for the First Quarter of 2016 1Q16 Total Sales Up 29.4% with Non-GAAP Net Income Up 29.8% YoY in RMB terms, or Up 21.6% YoY to $85.6 Million and 21.6% YoY to $30.4 Million in USD terms, respectively BEIJING, China – May 4, 2016 – First Quarter 2016 Financial Highlights] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 4, 2016 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6598-3111 ____________________________________________________________ (Former name or former]

By | 2016-05-08T01:51:57+00:00 May 4th, 2016|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] DEFA14A: (Original Filing)

[SCHEDULE 14A x ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material under Rule 14a-12 CHINA BIOLOGIC PRODUCTS, INC. ________________________________________________________ Payment of Filing Fee (Check the appropriate box): x No fee required ¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of]

By | 2016-05-08T01:57:04+00:00 April 29th, 2016|Categories: CBPO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] DEFA14A: SCHEDULE 14A x ¨ Check the appropriate box:

[SCHEDULE 14A x ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material under Rule 14a-12 CHINA BIOLOGIC PRODUCTS, INC. ________________________________________________________ Payment of Filing Fee (Check the appropriate box): x No fee required ¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of]

By | 2016-05-08T01:57:59+00:00 April 29th, 2016|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] SC 13G/A: (Original Filing)

[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital World Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 2,867,323 6 SHARED VOTING POWER NUMBER OF SHARES NONE BENEFICIALL Y OWNED BY]

By | 2016-04-09T03:40:15+00:00 April 8th, 2016|Categories: CBPO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] SC 13G/A: 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.

[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital World Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 2,867,323 6 SHARED VOTING POWER NUMBER OF SHARES NONE BENEFICIALL Y OWNED BY]

By | 2016-04-09T03:41:08+00:00 April 8th, 2016|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] SC 13D/A: CUSIP No. 16938C106 1. Names of reporting persons.

[CUSIP No. 16938C106 1. Names of reporting persons. WP X Biologics LLC 2. Check the appropriate box if a member of a group (see instructions). ¨ x (a) 3. SEC use only 4. Source of funds (see instructions) N/A 5. ¨]

By | 2016-03-25T03:01:16+00:00 March 8th, 2016|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar